Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) Return on Invested Capital (2021 - 2025)

Beauty Health (SKIN) has disclosed Return on Invested Capital for 5 consecutive years, with 0.37% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital rose 92.0% to 0.37% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.37%, a 92.0% increase, with the full-year FY2024 number at 1.2%, down 6.0% from a year prior.
  • Return on Invested Capital was 0.37% for Q3 2025 at Beauty Health, up from 0.74% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.03% in Q3 2022 to a low of 2.19% in Q2 2024.
  • A 5-year average of 0.82% and a median of 0.62% in 2021 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: tumbled -206bps in 2024, then surged 145bps in 2025.
  • Beauty Health's Return on Invested Capital stood at 0.51% in 2021, then soared by 76bps to 0.12% in 2022, then tumbled by -1328bps to 1.72% in 2023, then surged by 31bps to 1.19% in 2024, then surged by 69bps to 0.37% in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Return on Invested Capital are 0.37% (Q3 2025), 0.74% (Q2 2025), and 1.32% (Q1 2025).